262 related articles for article (PubMed ID: 23891221)
1. Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates.
Fehlberg LC; Andrade LH; Assis DM; Pereira RH; Gales AC; Marques EA
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):126-8. PubMed ID: 23891221
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different molecular and phenotypic methods for identification of environmental Burkholderia cepacia complex.
Furlan JPR; Pitondo-Silva A; Braz VS; Gallo IFL; Stehling EG
World J Microbiol Biotechnol; 2019 Feb; 35(3):39. PubMed ID: 30739255
[TBL] [Abstract][Full Text] [Related]
3. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
[TBL] [Abstract][Full Text] [Related]
4. RecA gene sequence and Multilocus Sequence Typing for species-level resolution of Burkholderia cepacia complex isolates.
Cesarini S; Bevivino A; Tabacchioni S; Chiarini L; Dalmastri C
Lett Appl Microbiol; 2009 Nov; 49(5):580-8. PubMed ID: 19732325
[TBL] [Abstract][Full Text] [Related]
5. Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of
Wong KSK; Dhaliwal S; Bilawka J; Srigley JA; Champagne S; Romney MG; Tilley P; Sadarangani M; Zlosnik JEA; Chilvers MA
J Med Microbiol; 2020 Aug; 69(8):1105-1113. PubMed ID: 32597748
[No Abstract] [Full Text] [Related]
6. Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.
Vicenzi FJ; Pillonetto M; Souza HA; Palmeiro JK; Riedi CA; Rosario-Filho NA; Dalla-Costa LM
Mem Inst Oswaldo Cruz; 2016 Jan; 111(1):37-42. PubMed ID: 26814642
[TBL] [Abstract][Full Text] [Related]
7. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
[TBL] [Abstract][Full Text] [Related]
9. Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars.
Turton JF; Arif N; Hennessy D; Kaufmann ME; Pitt TL
J Clin Microbiol; 2007 Sep; 45(9):3105-8. PubMed ID: 17626169
[TBL] [Abstract][Full Text] [Related]
10. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
[TBL] [Abstract][Full Text] [Related]
11. Assignment of recA reference sequence types for enhanced identification of the Burkholderia cepacia complex.
Kong Q; Xiao M; Kong F; Yuen M; Brown M; Ng J; Ahuja V; Hicks L; Shen L; Xu H; Sintchenko V; Gilbert GL; James G
Pathology; 2012 Jun; 44(4):373-5. PubMed ID: 22565325
[No Abstract] [Full Text] [Related]
12. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
[TBL] [Abstract][Full Text] [Related]
13. Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry for identification of clinically significant bacteria that are difficult to identify in clinical laboratories.
Lau SK; Tang BS; Teng JL; Chan TM; Curreem SO; Fan RY; Ng RH; Chan JF; Yuen KY; Woo PC
J Clin Pathol; 2014 Apr; 67(4):361-6. PubMed ID: 24143023
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of commercial systems VITEK 2 and API 20NE for identification of Burkholderia cepacia complex bacteria from clinical samples].
Oderiz S; Palau MJ; Del Palacio P; Lewis MC; Bettiol MP; Martina P; Bosch A; Yantorno OM; Gatti BM
Rev Argent Microbiol; 2011; 43(3):168-75. PubMed ID: 22430988
[TBL] [Abstract][Full Text] [Related]
15. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.
Nagy E; Maier T; Urban E; Terhes G; Kostrzewa M;
Clin Microbiol Infect; 2009 Aug; 15(8):796-802. PubMed ID: 19438622
[TBL] [Abstract][Full Text] [Related]
16. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
Seo ST; Tsuchiya K
Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
[TBL] [Abstract][Full Text] [Related]
19. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update.
Devanga Ragupathi NK; Veeraraghavan B
Ann Clin Microbiol Antimicrob; 2019 Feb; 18(1):7. PubMed ID: 30717798
[TBL] [Abstract][Full Text] [Related]
20. Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia.
Storms V; Van Den Vreken N; Coenye T; Mahenthiralingam E; LiPuma JJ; Gillis M; Vandamme P
Syst Appl Microbiol; 2004 Sep; 27(5):517-26. PubMed ID: 15490552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
